81 Biggest Movers From Yesterday
Gainers
Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results.
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
electroCore Reports Its gammaCore Device Selected For US Dept. OF Defense Biotech Optimized For Operational Solutions, Tactics Program, No Terms Disclosed
electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine company, today announced that gammaCore™ nVNS has been selected for further study under the United States Department of Defense
Earnings Preview For electroCore
electroCore (NASDAQ:ECOR) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement.
Analysts estimate that electroCore will report an earnings per share (EPS) of $-0.07.
ElectroCore Granted U.S. Patent Titled ‘Nerve stimulator for use with a mobile device’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11260225.PN.&OS=PN/11260225&RS=PN/11260225
ECOR: Different Strokes for Different Folks
By John Vandermosten, CFA
NASDAQ:ECOR
READ THE FULL ECOR RESEARCH REPORT
electroCore, Inc. Announces Completion Of Enrollment In The TRANSIT Study Of non-Invasive Vagus Nerve Stimulation In Post-Operative Ileus
electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine company, today announced enrollment has been completed for the TRANSIT study of non-invasive vagal nerve stimulation (nVNS) to reduce ileus
ElectroCore Granted U.S. Patent Titled ‘Mobile phone for treating a patient with seizures’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11229790.PN.&OS=PN/11229790&RS=PN/11229790